Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × HER2-positive Breast Cancer × trastuzumab deruxtecan × Clear all

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Neoplasm Metastasis 5 Neoplasms 4 Adenocarcinoma 3 Stomach Neoplasms 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Meningeal Carcinomatosis 1 HER2-positive Breast Cancer 1 Gastrointestinal Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Trastuzumab 3 pyrotinib 2 tucatinib 1 trastuzumab deruxtecan 1 pertuzumab 1 atezolizumab 1 Hospital Information Systems 1 Electronic Health Records 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05458401 2024-03-15

EUROPA T-DXd

Daiichi Sankyo

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡